Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis

BACKGROUND: Duchenne muscular dystrophy (DMD) is characterized by the absence of the cytoskeletal protein dystrophin, muscle wasting, increased transforming growth factor type beta (TGF-β) signaling, and fibrosis. At the present time, the only clinically validated treatments for DMD are glucocortico...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cabrera, Daniel, Gutiérrez, Jaime, Cabello-Verrugio, Claudio, Morales, Maria Gabriela, Mezzano, Sergio, Fadic, Ricardo, Casar, Juan Carlos, Hancke, Juan L, Brandan, Enrique
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4021597/
https://ncbi.nlm.nih.gov/pubmed/24655808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2044-5040-4-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia